Arrive AI Inc. (ARAI): Nasdaq/NYSE listing notice — Arrive AI receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period until Nov 30, 2026
Arrive AI Inc.
Deficiency letter received June 2, 2026 for failing to maintain minimum bid price of $1.00 over 30 consecutive business days.
Compliance period of 180 days expires November 30, 2026; requires closing bid >=$1.00 for 10 consecutive business days.
If not cured by deadline, may qualify for a second 180-day period if all other initial listing standards are met.
Company will monitor and evaluate options but cannot assure compliance or avoid eventual delisting.
Arrive AI Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
Exchange
nasdaq
Notice
deficiency notice
Deficiency
minimum bid price
Rules
5450(a)(1)
Exact text from the filing
June 2, 2026, Arrive AI Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock, par value $0.0002 per share (the “Common Stock”), for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Global Market, as set forth in Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requ
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.